Navigation Links
Surgical site infections more common than expected following breast procedures
Date:1/21/2008

Infections at the incision site occurred in more than 5 percent of patients following breast surgery and cost them more than $4,000 each in hospital-related expenses, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals.

Reported surgical site infection rates following mastectomy (surgical removal of the breast) and other breast procedures range from 1 percent to 28 percent, according to background information in the article. Given the state of fiscal constraints within the U.S. health care system, it is important to calculate the cost-effectiveness of infection control interventions to justify their use from an economic perspective, the authors write. Cost-effectiveness analyses require accurate estimates for the attributable costs of hospital-acquired infections, which are lacking for surgical site infections.

Margaret A. Olsen, Ph.D., M.P.H., of the Washington University School of Medicine, St. Louis, and colleagues studied 949 hospital admissions for mastectomy or breast reconstruction procedures at a university-affiliated hospital between 1999 and 2002. Surgical site infections were identified in an electronic hospital database and verified by review of medical records. Costs were taken from the hospital accounting database and included those from the original admission to the hospital for surgery as well as any readmissions within one year of surgery.

Surgical site infections were identified in 50 women within one year of surgery (5.3 percent). Infections were more common in patients undergoing cancer-related procedures, and occurred following 12.4 percent of mastectomies with immediate breast reconstruction using an implant; 6.2 percent of mastectomies with immediate breast reconstruction using abdominal tissue; 4.4 percent of mastectomies only and 1.1 percent of breast reduction surgeries. The average time between surgery and infection diagnosis was 46.6 days.

Patients with surgical site infections had significantly higher hospital costs associated with surgery and during the one-year period after surgery compared with uninfected patients, and they had a significantly longer total length of hospital stay, the authors write. After adjusting for the type of surgical procedure performed, breast cancer stage and other variables that influence cost, the cost of surgical site infections was $4,091 per patient.

Potential interventions to reduce the incidence of surgical site infections in this patient population include strategies to optimize the timing and dosage of prophylactic antibiotics administered before the surgical incision, glucose control in diabetic patients, promotion of meticulous hand hygiene and strategies to promote timely removal of drains, among others, the authors conclude. Interventions to reduce the incidence of surgical site infections following breast cancer surgical procedures are essential to reduce not only morbidity in these patient populations but also costs to the individuals and to society.


'/>"/>

Contact: Caroline Arbanas
314-286-0109
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
2. Older surgical patients at greater risk for developing cognitive problems
3. Surgical Care Affiliates and UCSD Medical Center to Partner in Surgical Center
4. Early surgical treatment contributes to better outcomes in gallstone pancreatitis cases
5. Robotic device appears useful for surgical removal of cancer involving the tonsils
6. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
7. Surgical Care Affiliates Announces Investor Conference Call to Discuss Third Quarter 2007 Results
8. Smith & Nephew Endoscopy Expands Line of CLEAR-TRAC(TM) Surgical Cannulas
9. STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference
10. Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical
11. Surgical Care Affiliates Announces New Home Office Location
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... Splashtop Inc., the worldwide leader in high performance ... the leading provider of secure mobile remote access solution for Japan enterprises. ... remote access solution. Splashtop for CACHATTO will be available as an integrated ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices ... But this approach has proven transformative, both for people who hear voices and for ... is used around the world, but it still lags in the United States. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... When ... he knew it was something that contractors should have at their disposal on ... gets,” says Butch, CertainTeed’s Director of Contractor Programs. , As a result, ...
(Date:5/31/2016)... Severna Park, Maryland (PRWEB) , ... May 31, ... ... the ability to attribute calls back to particular advertising campaigns, to monitor the ... teams so that they can maximize conversions and revenue. The software allows customers ...
(Date:5/31/2016)... ... May 31, 2016 , ... Effective leaders not only drive service to ... a whole. On June 2, Northbound CEO Mike Neatherton and COO Paul Alexander will ... the opening plenary on “Leadership: The Journey to Authenticity” with Onsite Workshops CEO Miles ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... -- A key trend that will boost ... new treatments. Cardax, a development stage life sciences company, ... is expected to fulfil large unmet medical needs in ... to develop new treatments for osteoarthritis. One such study ... osteoarthritis are being investigated, and early trials of stem-cell ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology: